Managing patients with resistant rheumatoid arthritis.
This article describes the management of patients with difficult to treat rheumatoid arthritis. Pharmacological treatment of patients using disease-modifying and biologic drugs is discussed. Clinical measures of disease activity are also described.
Madden
Julie
J
Calderdale Royal Hospital, Halifax. Julie.madden@cht.nhs.uk
D018501:Antirheumatic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000175:diagnosis* / Q000209:etiology / Q000523:psychology / Q000628:therapy*; D001294:Attitude to Health; D018450:Disease Progression; D016903:Drug Monitoring; D004351:Drug Resistance; D006301:Health Services Needs and Demand; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D024802:Nurse's Role; D009730:Nursing Assessment; D010348:Patient Care Team; D011379:Prognosis; D012017:Referral and Consultation; D012307:Risk Factors; D012720:Severity of Illness Index; D017211:Treatment Failure
D018501:Antirheumatic Agents; D007155:Immunologic Factors; D007166:Immunosuppressive Agents